Interim Analysis of a Trial Evaluating the Utility of Non-Targeted Biopsies for Colorectal Neoplasia Detection in Inflammatory Bowel Disease
Sanjay K. Murthy(University of Ottawa), Jennifer Ramsay, Geoffrey C. Nguyen(Johns Hopkins Medicine), Çharles N. Bernstein(University of Manitoba), Robert H. Riddell(Mount Sinai Hospital), Mark Borgaonkar, Talat Bessissow(Montreal General Hospital), James Conner(Mount Sinai Hospital), Frank Hoentjen(Radboud University Nijmegen), Faria Ahmed, Petros Zezos(Mount Sinai Hospital), Brian Bressler(University of British Columbia), Dean Fergusson(Ottawa Hospital), Dustin Loomes(Island Health), Jennifer M. Jones, Jane Castelli(McMaster University Medical Centre), Daniel C. Baumgart, Tim Ramsay(University of Ottawa), Neeraj Narula, Vipul Jairath(Western University)
Cited by 4
Related Papers
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
|Cochrane Database of Systematic Reviews|2016|1.2k
Environmental triggers in IBD: a review of progress and evidence
|Nature Reviews Gastroenterology & Hepatology|2017|931